Anna Protopapas

2019

In 2019, Anna Protopapas earned a total compensation of $1.7M as Chief Executive Officer and President at Mersana Therapeutics, a 33% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$293,150
Option Awards$506,645
Salary$533,000
Stock Awards$400,000
Other$7,000
Total$1,739,795

Protopapas received $533K in salary, accounting for 31% of the total pay in 2019.

Protopapas also received $293.2K in non-equity incentive plan, $506.6K in option awards, $400K in stock awards and $7K in other compensation.

Rankings

In 2019, Anna Protopapas' compensation ranked 6,598th out of 13,971 executives tracked by ExecPay. In other words, Protopapas earned more than 52.8% of executives.

ClassificationRankingPercentile
All
6,598
out of 13,971
53rd
Division
Manufacturing
2,507
out of 5,695
56th
Major group
Chemicals And Allied Products
909
out of 2,194
59th
Industry group
Drugs
769
out of 1,880
59th
Industry
Pharmaceutical Preparations
564
out of 1,392
60th
Source: SEC filing on April 20, 2020.

Protopapas' colleagues

We found four more compensation records of executives who worked with Anna Protopapas at Mersana Therapeutics in 2019.

2019

Dirk Huebner

Mersana Therapeutics

Chief Medical Officer

2019

Brian DeSchuytner

Mersana Therapeutics

Senior Vice President, Finance & Product Strategy

2019

Timothy Lowinger

Mersana Therapeutics

Chief Science and Technology Officer

2019

Michael Kaufman

Mersana Therapeutics

Chief Manufacturing Officer

News

You may also like